126 related articles for article (PubMed ID: 38484677)
1. Scaffold hopping derived novel benzoxazepinone receptor-interacting protein kinase 1 (RIP1) inhibitors as anti-necroptosis agents: Anti-inflammatory effect in systemic inflammatory response syndrome (SIRS) and epilepsy.
Jiang R; Xu B; Zhi S; Sun L; Yu B; Huang Q; Shi Y
Eur J Med Chem; 2024 Apr; 269():116304. PubMed ID: 38484677
[TBL] [Abstract][Full Text] [Related]
2. Scaffold hopping derived novel benzoxazepinone RIPK1 inhibitors as anti-necroptosis agents.
Tang J; Wu Y; Zhao W; Qu Z; Yu J; Wang Z; Shi Y
Bioorg Med Chem; 2023 Aug; 91():117385. PubMed ID: 37364415
[TBL] [Abstract][Full Text] [Related]
3. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
Shrestha A; Mehdizadeh Gohari I; McClane BA
mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
[No Abstract] [Full Text] [Related]
4. Discovery of novel 5-phenylpyrazol receptor interacting protein 1(RIP1) kinase inhibitors as anti-necroptosis agents by combining virtual screening and in vitro and in vivo experimental evaluations.
Shi Y; Tang J; Zhi S; Jiang R; Huang Q; Sun L; Wang Z; Wu Y
Bioorg Chem; 2024 Jan; 142():106964. PubMed ID: 37976678
[TBL] [Abstract][Full Text] [Related]
5. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation.
Hu S; Chang X; Zhu H; Wang D; Chen G
Cytokine; 2020 May; 129():155046. PubMed ID: 32114297
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.
Wu XN; Yang ZH; Wang XK; Zhang Y; Wan H; Song Y; Chen X; Shao J; Han J
Cell Death Differ; 2014 Nov; 21(11):1709-20. PubMed ID: 24902902
[TBL] [Abstract][Full Text] [Related]
8. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.
Marunouchi T; Nishiumi C; Iinuma S; Yano E; Tanonaka K
Eur J Pharmacol; 2021 May; 898():173987. PubMed ID: 33640405
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors.
Xin Y; Dai P; Shao H; Zhuang C; Li J
Bioorg Med Chem; 2024 Feb; 100():117611. PubMed ID: 38309200
[TBL] [Abstract][Full Text] [Related]
10. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
Lin QS; Chen P; Wang WX; Lin CC; Zhou Y; Yu LH; Lin YX; Xu YF; Kang DZ
Lab Invest; 2020 Mar; 100(3):503-511. PubMed ID: 31506635
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis in health and diseases.
Zhou W; Yuan J
Semin Cell Dev Biol; 2014 Nov; 35():14-23. PubMed ID: 25087983
[TBL] [Abstract][Full Text] [Related]
12. Receptor-interacting protein 3-phosphorylated Ca
Yuan G; Cao C; Cao D; Li B; Li X; Li H; Shen H; Wang Z; Chen G
J Neurochem; 2023 Jan; 164(1):94-114. PubMed ID: 36424866
[TBL] [Abstract][Full Text] [Related]
13. Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation.
Zhang Y; Li M; Li X; Zhang H; Wang L; Wu X; Zhang H; Luo Y
Cell Death Dis; 2020 Jul; 11(7):565. PubMed ID: 32703968
[TBL] [Abstract][Full Text] [Related]
14. GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stress.
Zhang XJ; Li L; Wang AL; Guo HX; Zhao HP; Chi RF; Xu HY; Yang LG; Li B; Qin FZ; Wang JP
Toxicol Appl Pharmacol; 2023 Mar; 463():116412. PubMed ID: 36764612
[TBL] [Abstract][Full Text] [Related]
15. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
Zhang L; Feng Q; Wang T
Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury.
Hu Y; Pan H; Peng J; He J; Tang M; Yan S; Rong J; Li J; Zheng Z; Wang H; Liu Y; Zhong X
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):430-437. PubMed ID: 33686403
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of necroptosis by Porphyromonas gingivalis in periodontitis development.
Ke X; Lei L; Li H; Li H; Yan F
Mol Immunol; 2016 Sep; 77():8-13. PubMed ID: 27449906
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.
Feng Y; Wang W; Zhang Y; Fu X; Ping K; Zhao J; Lei Y; Mou Y; Wang S
Eur J Med Chem; 2022 Feb; 229():114070. PubMed ID: 34968902
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin induces NADPH oxidase activation and receptor‑interacting protein kinase 1‑mediated necroptosis in gastric cancer AGS cells.
Kim S; Lee H; Lim JW; Kim H
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
